The use of unequal randomisation ratios in clinical trials: A review

Jo C Dumville(Manchester Academic Health Science Centre), David Torgerson(University of York), Jeremy N. V. Miles(York Hospital), Seokyung Hahn(Seoul National University Hospital)

Contemporary Clinical Trials

October 20, 2005

10.1016/j.cct.2005.08.003

Cited by 322

Related Papers

The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women

|Osteoporosis International|2007|1.2k

Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial

|The Lancet|2005|976

CONSORT 2025 statement: updated guideline for reporting randomised trials

|BMJ|2025|847

Guidelines for diagnosis and management of osteoporosis

|Osteoporosis International|1997|793

Understanding controlled trials: What are pragmatic trials?

|BMJ|1998|721